iZafe Group AB Series B
iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated medication dispenser that handles medication pouches, smart pillboxes, facilitates and enables independent medication, and reminds and alerts in the scheduled doses. It also o… Read more
iZafe Group AB Series B (IZAFE-B) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.175x
Based on the latest financial reports, iZafe Group AB Series B (IZAFE-B) has a cash flow conversion efficiency ratio of -0.175x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.89 Million) by net assets (Skr16.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
iZafe Group AB Series B - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how iZafe Group AB Series B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
iZafe Group AB Series B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iZafe Group AB Series B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Healthconn Corp.
TWO:6665
|
0.072x |
|
Asia Precision Public Company Limited
BK:APCS
|
0.070x |
|
Thai Rubber Latex Group Public Company Limited
BK:TRUBB
|
-0.011x |
|
Laredo Oil Inc
PINK:LRDC
|
0.049x |
|
AlzeCure Pharma
ST:ALZCUR
|
-0.150x |
|
Rocky Mountain Chocolate Factory
NASDAQ:RMCF
|
-0.206x |
|
Wellysun Inc
TW:6988
|
0.073x |
|
Radhika Jeweltech Limited
NSE:RADHIKAJWE
|
0.003x |
Annual Cash Flow Conversion Efficiency for iZafe Group AB Series B (2012–2024)
The table below shows the annual cash flow conversion efficiency of iZafe Group AB Series B from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr9.73 Million | Skr-11.36 Million | -1.167x | -162.91% |
| 2023-12-31 | Skr25.35 Million | Skr-11.26 Million | -0.444x | +19.39% |
| 2022-12-31 | Skr38.96 Million | Skr-21.46 Million | -0.551x | +33.02% |
| 2021-12-31 | Skr40.73 Million | Skr-33.49 Million | -0.822x | +1.40% |
| 2020-12-31 | Skr29.46 Million | Skr-24.57 Million | -0.834x | -100.85% |
| 2019-12-31 | Skr36.89 Million | Skr-15.32 Million | -0.415x | -197.93% |
| 2018-12-31 | Skr10.12 Million | Skr-1.41 Million | -0.139x | +58.08% |
| 2017-12-31 | Skr11.19 Million | Skr-3.72 Million | -0.332x | +58.28% |
| 2016-12-31 | Skr5.42 Million | Skr-4.32 Million | -0.797x | -292.09% |
| 2015-12-31 | Skr8.72 Million | Skr-1.77 Million | -0.203x | -121.50% |
| 2014-12-31 | Skr9.04 Million | Skr-829.55K | -0.092x | -13.91% |
| 2013-12-31 | Skr11.69 Million | Skr-941.32K | -0.081x | +6.07% |
| 2012-12-31 | Skr18.92 Million | Skr-1.62 Million | -0.086x | -- |